Skip to results
Modify your search
NARROW
1-20 of 21
Authors: Christoph Wanner
Journal Article
Incident hyperkalaemia risk model in chronic kidney disease and diabetes: the FIDELITY programme
European Heart Journal, ehaf258, https://doi.org/10.1093/eurheartj/ehaf258
Published: 22 April 2025
Journal Article
Empagliflozin in resistant hypertension and heart failure with preserved ejection fraction: the EMPEROR-Preserved trial
European Heart Journal, Volume 46, Issue 14, 7 April 2025, Pages 1304–1317, https://doi.org/10.1093/eurheartj/ehae938
Published: 04 March 2025
Journal Article
Empagliflozin, irrespective of blood pressure, improves outcomes in heart failure with preserved ejection fraction: the EMPEROR-Preserved trial
European Heart Journal, Volume 44, Issue 5, 1 February 2023, Pages 396–407, https://doi.org/10.1093/eurheartj/ehac693
Published: 07 December 2022
Journal Article
Kidney function assessment and endpoint ascertainment in clinical trials
European Heart Journal, Volume 43, Issue 14, 7 April 2022, Pages 1379–1400, https://doi.org/10.1093/eurheartj/ehab832
Published: 30 December 2021
Journal Article
GUIDELINES
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC)
European Heart Journal, Volume 42, Issue 34, 7 September 2021, Pages 3227–3337, https://doi.org/10.1093/eurheartj/ehab484
Published: 30 August 2021
Journal Article
EDITOR'S CHOICE
Relationship between hypoglycaemia, cardiovascular outcomes, and empagliflozin treatment in the EMPA-REG OUTCOME® trial
European Heart Journal, Volume 41, Issue 2, 7 January 2020, Pages 209–217, https://doi.org/10.1093/eurheartj/ehz621
Published: 31 August 2019
Journal Article
Heart failure and diabetes: metabolic alterations and therapeutic interventions: a state-of-the-art review from the Translational Research Committee of the Heart Failure Association–European Society of Cardiology
European Heart Journal, Volume 39, Issue 48, 21 December 2018, Pages 4243–4254, https://doi.org/10.1093/eurheartj/ehy596
Published: 08 October 2018
Journal Article
Chronic kidney disease and arrhythmias: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
European Heart Journal, Volume 39, Issue 24, 21 June 2018, Pages 2314–2325, https://doi.org/10.1093/eurheartj/ehy060
Published: 07 March 2018
Journal Article
Treatment of hypertrophic cardiomyopathy caused by cardiospecific variants of Fabry disease with chaperone therapy
European Heart Journal, Volume 39, Issue 20, 21 May 2018, Pages 1861–1862, https://doi.org/10.1093/eurheartj/ehy072
Published: 14 February 2018
Journal Article
EDITOR'S CHOICE
Effects of empagliflozin on risk for cardiovascular death and heart failure hospitalization across the spectrum of heart failure risk in the EMPA-REG OUTCOME® trial Get access
European Heart Journal, Volume 39, Issue 5, 01 February 2018, Pages 363–370, https://doi.org/10.1093/eurheartj/ehx511
Published: 28 August 2017
Journal Article
Cardiovascular outcome trials in patients with chronic kidney disease: challenges associated with selection of patients and endpoints
European Heart Journal, Volume 40, Issue 11, 14 March 2019, Pages 880–886, https://doi.org/10.1093/eurheartj/ehx209
Published: 18 April 2017
Journal Article
EDITOR'S CHOICE
FAST TRACK
Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME® trial
European Heart Journal, Volume 37, Issue 19, 14 May 2016, Pages 1526–1534, https://doi.org/10.1093/eurheartj/ehv728
Published: 26 January 2016
Journal Article
Lowering cholesterol in chronic kidney disease: is it safe and effective? Get access
European Heart Journal, Volume 36, Issue 43, 14 November 2015, Pages 2988–2995, https://doi.org/10.1093/eurheartj/ehv393
Published: 19 August 2015
Journal Article
Serum amyloid A: high-density lipoproteins interaction and cardiovascular risk Get access
European Heart Journal, Volume 36, Issue 43, 14 November 2015, Pages 3007–3016, https://doi.org/10.1093/eurheartj/ehv352
Published: 06 August 2015
Journal Article
Two-dimensional speckle tracking as a non-invasive tool for identification of myocardial fibrosis in Fabry disease Get access
European Heart Journal, Volume 34, Issue 21, 1 June 2013, Pages 1587–1596, https://doi.org/10.1093/eurheartj/eht098
Published: 21 March 2013
Journal Article
Aldosterone and cortisol affect the risk of sudden cardiac death in haemodialysis patients
European Heart Journal, Volume 34, Issue 8, 21 February 2013, Pages 578–587, https://doi.org/10.1093/eurheartj/ehs361
Published: 04 December 2012
Journal Article
EDITOR'S CHOICE
Vitamin D deficiency is associated with sudden cardiac death, combined cardiovascular events, and mortality in haemodialysis patients
European Heart Journal, Volume 31, Issue 18, September 2010, Pages 2253–2261, https://doi.org/10.1093/eurheartj/ehq246
Published: 05 August 2010
Journal Article
Change in N-terminal-pro-B-type-natriuretic-peptide and the risk of sudden death, stroke, myocardial infarction, and all-cause mortality in diabetic dialysis patients
European Heart Journal, Volume 29, Issue 19, October 2008, Page 2445, https://doi.org/10.1093/eurheartj/ehn405
Published: 01 October 2008
Journal Article
Change in N-terminal-pro-B-type-natriuretic-peptide and the risk of sudden death, stroke, myocardial infarction, and all-cause mortality in diabetic dialysis patients
European Heart Journal, Volume 29, Issue 17, September 2008, Pages 2092–2099, https://doi.org/10.1093/eurheartj/ehn278
Published: 09 July 2008
Journal Article
A new echocardiographic approach for the detection of non-ischaemic fibrosis in hypertrophic myocardium Get access
European Heart Journal, Volume 28, Issue 24, December 2007, Pages 3020–3026, https://doi.org/10.1093/eurheartj/ehm454
Published: 01 November 2007
